Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Aurinia Pharm Ord (AUPH)

Aurinia Pharm Ord (AUPH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
8.18 +0.08 (+0.99%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 8.18 unch (unch) 16:34 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
7.97
Day High
8.21
Open 8.05
Previous Close 8.10 8.10
Volume 808,900 808,900
Avg Vol 1,292,155 1,292,155
Stochastic %K 86.89% 86.89%
Weighted Alpha +55.01 +55.01
5-Day Change +0.43 (+5.55%) +0.43 (+5.55%)
52-Week Range 4.86 - 10.67 4.86 - 10.67
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,067,205
  • Shares Outstanding, K 136,646
  • Annual Sales, $ 235,130 K
  • Annual Income, $ 5,750 K
  • EBIT $ -9 M
  • EBITDA $ 10 M
  • 60-Month Beta 1.20
  • Price/Sales 4.75
  • Price/Cash Flow 26.52
  • Price/Book 3.05

Options Overview Details

View History
  • Implied Volatility 44.46% ( -7.54%)
  • Historical Volatility 38.03%
  • IV Percentile 8%
  • IV Rank 11.97%
  • IV High 110.57% on 07/12/24
  • IV Low 35.48% on 10/15/24
  • Put/Call Vol Ratio 0.07
  • Today's Volume 487
  • Volume Avg (30-Day) 945
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 40,487
  • Open Int (30-Day) 59,723

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.09
  • Number of Estimates 3
  • High Estimate 0.11
  • Low Estimate 0.07
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.82 +19.94%
on 04/09/25
Period Open: 8.67
8.73 -6.30%
on 03/26/25
-0.49 (-5.65%)
since 03/25/25
3-Month
6.55 +24.89%
on 02/27/25
Period Open: 8.00
8.85 -7.52%
on 03/05/25
+0.18 (+2.25%)
since 01/24/25
52-Week
4.86 +68.31%
on 04/26/24
Period Open: 4.87
10.67 -23.34%
on 12/10/24
+3.31 (+67.97%)
since 04/25/24

Most Recent Stories

More News
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics

For Immediate ReleaseChicago, IL – April 24, 2025 – Today, Zacks Equity Research discusses Aurinia Pharmaceuticals AUPH, Heron Therapeutics HRTX, Esperion Therapeutics ESPR, Pyxis Oncology PYXS and...

ESPR : 0.9200 (+4.39%)
PSTV : 0.7879 (-6.50%)
PYXS : 1.0600 (-2.75%)
AUPH : 8.18 (+0.99%)
HRTX : 2.30 (+1.32%)
Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet

Over the past three months, Mainz has seen a staggering 2,500% increase in message volume on Stocktwits, while Aurinia’s engagement has grown just 23%.

AUPH : 8.18 (+0.99%)
MYNZ : 3.53 (+10.31%)
Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals (AUPH) Stock?

Investors in Aurinia Pharmaceuticals Inc. AUPH need to pay close attention to the stock based on moves in the options market lately. That is because the April 17, 2025 $4 Call had some of the highest implied...

AUPH : 8.18 (+0.99%)
Aurinia: Q4 Earnings Snapshot

Aurinia: Q4 Earnings Snapshot

AUPH : 8.18 (+0.99%)
Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options

Investors in Aurinia Pharmaceuticals Inc. AUPH need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $20 Put had some of the highest implied...

AUPH : 8.18 (+0.99%)
Aurinia Pharma Surges Pre-Market After Director Kevin Tang Discloses $10M Stock Buy: Retail Confidence Spikes

Aurinia has been under the spotlight recently due to significant restructuring efforts.

AUPH : 8.18 (+0.99%)
Insider Purchase: Director at $AUPH (AUPH) Buys 300,000 Shares

KEVIN TANG, a director at $AUPH ($AUPH), bought 300,000 shares of the company on 12-05-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings...

AUPH : 8.18 (+0.99%)
10 Stocks Retailers On Stocktwits Are Most Bullish/Bearish About To Start The Week

As the new week unfolds, earnings and economic data will again dictate sentiment.

MARA : 14.30 (+2.07%)
BLK : 907.69 (-0.94%)
NFLX : 1,101.53 (+0.42%)
PDD : 104.01 (+0.72%)
AUPH : 8.18 (+0.99%)
CKPT : 4.10 (+0.24%)
EVH : 8.98 (-1.21%)
EBS : 5.49 (+2.23%)
BIDU : 90.74 (+1.39%)
SPY : 550.64 (+0.72%)
COIN : 209.64 (+2.83%)
Aurinia Pharmaceuticals Soars After Earnings Beat, Strategic Overhaul: Retail Sentiment Turns Extremely Bullish

Aurinia plans to slash 45% of its entire workforce with an aim to save more than $40 million in annual operating expenses.

IWO : 252.41 (+0.30%)
AUPH : 8.18 (+0.99%)
IWM : 194.12 (+0.03%)
Aurinia: Q3 Earnings Snapshot

Aurinia: Q3 Earnings Snapshot

AUPH : 8.18 (+0.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

See More

Key Turning Points

3rd Resistance Point 8.51
2nd Resistance Point 8.36
1st Resistance Point 8.27
Last Price 8.18
1st Support Level 8.03
2nd Support Level 7.88
3rd Support Level 7.79

See More

52-Week High 10.67
Fibonacci 61.8% 8.45
Last Price 8.18
Fibonacci 50% 7.77
Fibonacci 38.2% 7.08
52-Week Low 4.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective